Posted by Michael Wonder on 22 Oct 2020
AppliedVR receives FDA breakthrough device designation to treat pain with digital therapeutic
21 October 2020 - AppliedVR today announced its EaseVRx product received breakthrough device designation from the U.S. FDA for treating treatment-resistant fibromyalgia and chronic intractable lower back pain.
EaseVRx is now one of the first virtual reality digital therapeutics to get breakthrough designation to treat conditions related to chronic pain.
